Qing Zhang

Professor at UT Southwestern Medical Center, Study hypoxia, oxygen sensing pathway and VHL pathway in cancers, including breast and kidney cancers.

[Qing Zhang @QingZhangLab]

@ACKoongMDPhD @UTMDAnderson @NobelPrize From left to right: Bill Kaelin @kaelin_lab , Jim Allison, .., Fred Ramsdell, Carolyn Bertozzi and Gary Ruvkun. All star lineups!

[Qing Zhang @QingZhangLab]

@ACKoongMDPhD @theNAMedicine @lab_rezvani @UTMDAnderson Congratulations, Albert! Well deserved!!

[Qing Zhang @QingZhangLab]

@WeilongChen3 Thank you, Weilong!

[Qing Zhang @QingZhangLab]

Development of A10P3C, an isoform-selective inhibitor of EGLN2, for targeting breast cancer | PNAS https://t.co/bzS5tsLxAG

[Qing Zhang @QingZhangLab]

@MingqiHan Thank you, Mingqi! Hope all is well in Houston!

[Qing Zhang @QingZhangLab]

PHYHD1-mediated translational control regulates renal cell carcinoma progression: Molecular Cell https://t.co/xJzx3X23P6

[Molecular Cell @MolecularCell]

Online Now: PHYHD1-mediated translational control regulates renal cell carcinoma progression dlvr.​it/TVtQhR

[Qing Zhang @QingZhangLab]

@MolecularCell @utswcancer @UTSW_Pathology @JBrugarolas @KCPUTSW @ChenghengLiao @zhou_jian Free full text link below: https://t.co/IloJbflUio

[Qing Zhang @QingZhangLab]

Happy to share our latest study @MolecularCell on identifying PHYHD1 as a potent tumor suppressor in renal cancer by regulating protein translation. Thanks for the support from @utswcancer @UTSW_Pathology @JBrugarolas @KCPUTSW @ChenghengLiao @zhou_jian and many others

[Qing Zhang @QingZhangLab]

@DrChoueiri @jclinicalinvest @BraunMDPhD @YaleCancer @DanaFarber_GU @harvardmed @YaleIMed @DanaFarberNews @DanaFarber @MarcMachaalani @KashimaMDPhD @YochumZach totally agree, Toni. Congratulations to you all! This is a very nice study with reassuring data for belzutifan treatment in patients.

[Qing Zhang @QingZhangLab]

@KidneyCancer @WalterStadler5 Congratulations, Walter! So well deserved!!

[Qing Zhang @QingZhangLab]

@KidneyCancer @montypal Congratulations, Monty! Richly deserved!!

[Qing Zhang @QingZhangLab]

@KidneyCancer @VincentWenxinXu Congratulations, Vincent!! Well deserved!

[Qing Zhang @QingZhangLab]

@MingqiHan Thank you, Mingqi!

[Qing Zhang @QingZhangLab]

@Dr_Di_Zhao Thank you, Di!

[Qing Zhang @QingZhangLab]

@BoyiGan Thank you.

[Qing Zhang @QingZhangLab]

@CardioOncology Thanks!

[Qing Zhang @QingZhangLab]

Glad to share our latest publication @PNASNews on the development of EglN2 prolyl hydroxylase specific inhibitor in breast cancer. We appreciate the generous supports from @UTSWMedCenter @utswcancer @UTSW_Pathology on this study.

[Qing Zhang @QingZhangLab]

Thanks for posting. @utswcancer @UTSW_Pathology

[UTSW Simmons Cancer Center @utswcancer]

From Texas to Germany! 🌍 Today, Qing Zhang, M.D., UTSW Director of Investigative Pathology & CSO of our Breast Cancer Research Program, presented “Targeting Oxygen-Sensing Signaling in Cancer” at the HYPOX EU Forum in Essen, Germany.
#CancerResearch #UTSW #Hypoxia

[UTSW Simmons Cancer Center @utswcancer]

From Texas to Germany! 🌍 Today, Qing Zhang, M.D., UTSW Director of Investigative Pathology & CSO of our Breast Cancer Research Program, presented “Targeting Oxygen-Sensing Signaling in Cancer” at the HYPOX EU Forum in Essen, Germany.
#CancerResearch #UTSW #Hypoxia